Staff Profile
Leanne Cork
BRC Performance Manager
- Telephone: +44 (0) 191 208 1323
- Address: NIHR Newcastle Biomedical Research Centre
3rd Floor, Biomedical Research Building
Campus for Ageing and Vitality
Newcastle upon Tyne
NE4 5PL
Background
Responsibilities
I support the delivery of project activity, funded by the BRC, by ensuring progress against financial and milestone targets, highlighting and managing risks and capturing downstream outputs and success stories.
Previous Positions
- Data Manager - Newcastle University Business School (Newcastle University)
- Project Data Analyst (SPIRIT Trials) - Newcastle Clinical Trials Unit (Newcastle University)
- Project Manager - Faculty of Medical Sciences (Newcastle University)
- Stroke and Cardiovascular Research Group Administrator - Institute for Ageing and Health (Newcastle University)
- Grants Administrator - Joint Research Office (Newcastle University)
- RAE Assistant - University Research Office (Newcastle University)
- Research Grants Assistant - University Research Office (Newcastle University)
- Customer Services Assistant (Oxford University Press)
Qualifications
BSc (Jt Hons) Accounting and Mathematics (Newcastle University) 2005
Accredited Training
- Clinical Data Management (IAOCR) 2015
- Text Processing Advanced (OCR) 2008
Publications
-
Conference Proceedings (inc. Abstracts)
- Dickson J, Kennedy N, Cork LM, Foroni L, Hedgley CA, Copland M, Holyoake TL, O'Brien SG, Ramashoye B. Reliable Detection of Abl Tyrosine Kinase Domain Mutations to <1% Using NGS Data Quality Parsing and Corroboration of Overlapping Paired-End Sequences. In: 57th ASH Annual Meeting. 2015, Orlando, USA: American Society of Hematology.
- Labeit AM, Copland M, Cork LM, Hedgley CA, Foroni L, Osborne WL, Gills G, Apperley JF, Holyoake TL, Bescoby RV, Pocock C, Zwingers T, Burnell P, Byrne JL, McCullough JH, Goldman JM, Clark RE, O'Brien SG. Assessment of Quality of Life in the NCRI Spirit 2 Study Comparing Imatinib with Dasatinib in Patients with Newly-Diagnosed Chronic Phase Chronic Myeloid Leukaemia. In: 57th ASH Annual Meeting. 2015, Orlando, USA: American Society of Hematology.